Suresh Kumar
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cytokine Signaling Pathways and Interactions
- Chemokine receptors and signaling
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
-
- Ubiquitin and proteasome pathways 18
- Histone Deacetylase Inhibitors Research 5
- Oncology 14
- Cancer-related Molecular Pathways 8
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Serge Y. Fuchs (7 shared papers)Benjamin Nicholson (5 shared papers)Vladimir S. Spiegelman (3 shared papers)Harikrishna Nakshatri (3 shared papers)Hiromitsu Kishimoto (2 shared papers)Kathy D. Miller (2 shared papers)Hal E. Broxmeyer (1 shared paper)Kent W. Christopherson (1 shared paper)
- Journals
- Cancer Research (4 papers)Molecular and Cellular Biology (2 papers)Molecular Cancer Therapeutics (2 papers)Cell Biochemistry and Biophysics (2 papers)Oncogene (2 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Suresh Kumar
39 papers receiving 2.8k citations
Suresh Kumar's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.2k
- Cancer Research 453
- Immunology 607
- Molecular Biology 1.8k
- Cell Biology 301
Countries citing papers authored by Suresh Kumar
This map shows the geographic impact of Suresh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Kumar more than expected).
Fields of papers citing papers by Suresh Kumar
This network shows the impact of papers produced by Suresh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Kumar. The network helps show where Suresh Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Suresh Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4 Hit paper breakdown → | 2003 | 531 |
| 2 | 2011 | 313 | |
| 3 | 2006 | 300 | |
| 4 | 2004 | 270 | |
| 5 | 2011 | 199 | |
| 6 | 2003 | 162 | |
| 7 | 2012 | 155 | |
| 8 | 2005 | 132 | |
| 9 | 2004 | 119 | |
| 10 | 2007 | 117 | |
| 11 | 2017 | 88 | |
| 12 | 2006 | 71 | |
| 13 | 2004 | 67 | |
| 14 | 2003 | 66 | |
| 15 | 2011 | 46 | |
| 16 | 2005 | 42 | |
| 17 | 2016 | 27 | |
| 18 | 2016 | 25 | |
| 19 | 2021 | 21 | |
| 20 | 2018 | 21 |
About Suresh Kumar
Suresh Kumar is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Immunology, having authored 40 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (18 papers), Cancer-related Molecular Pathways (8 papers), NF-κB Signaling Pathways (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Autophagy in Disease and Therapy (4 papers), interferon and immune responses (3 papers), Immune cells in cancer (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (453 citations), Immunology (607 citations), Molecular Biology (1.8k citations) and Cell Biology (301 citations). Suresh Kumar has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Serge Y. Fuchs, Benjamin Nicholson, Vladimir S. Spiegelman, Harikrishna Nakshatri, Hiromitsu Kishimoto, Kathy D. Miller, Hal E. Broxmeyer, Kent W. Christopherson, Poornima Bhat‐Nakshatri and John J. Krolewski. Their work appears in journals such as Cancer Research, Molecular and Cellular Biology, Molecular Cancer Therapeutics, Cell Biochemistry and Biophysics and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.